LLY - Eli Lilly and Company

Mentioned as a big-pharma player leveraging frontier AI models (Fable 5.1) for drug discovery and trying to have 'good years.'

Mentioned as an example of a stock that could produce monthly income in a traditional $100k portfolio, but no specific endorsement given.

Mentioned as an example stock for an options income strategy in the masterclass, not as a standalone investment recommendation.

Mentioned as an example underlying stock for a covered call income strategy, not as a buy/sell recommendation.

Mentioned as an example stock in a $100k income-generating strategy that could produce about $900/month; no directional opinion given.

Mentioned as an example of a large-cap stock that could be used in an options income strategy to generate roughly $900/month with ~$100,000 capital.

Mentioned as an example stock requiring ~$100,000 to produce ~$900/month in income, illustrating capital inefficiency before promoting a more capital-efficient options income strategy.

Mentioned as an example of a high-quality stock for a covered call strategy to generate portfolio income.

Mentioned as an example of a stock position requiring ~$100,000 to generate ~$900/month in income, used to contrast with the speaker's alternative income strategy.

Mentioned as an example of a large-cap pharmaceutical stock for an income strategy producing roughly $900/month from a $100,000 position, to be discussed in the masterclass.